{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:27:57Z","timestamp":1778884077264,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.humpath.2012.08.023","type":"journal-article","created":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T11:18:41Z","timestamp":1356088721000},"page":"1011-1016","source":"Crossref","is-referenced-by-count":14,"title":["Micro-RNA-16 expression in paraffin-embedded specimen correlates with overall survival of T-lymphoblastic lymphoma\/leukemia"],"prefix":"10.1016","volume":"44","author":[{"given":"Yanfeng","family":"Xi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Likun","family":"Zan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2012.08.023_bb0005","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2012.08.023_bb0010","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11899-012-0123-4","article-title":"Recent developments in the management of T-cell precursor acute lymphoblastic leukemia\/lymphoma","volume":"7","author":"Fielding","year":"2012","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.humpath.2012.08.023_bb0015","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1182\/blood-2006-01-024729","article-title":"Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)","volume":"109","author":"Schultz","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2012.08.023_bb0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrclinonc.2010.167","article-title":"Prognostic factors in chronic lymphocytic leukemia-what do we need to know?","volume":"8","author":"Cramer","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.humpath.2012.08.023_bb0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/107327481201900103","article-title":"Clinical and laboratory prognostic indicators in chronic lymphocytic leukemia","volume":"19","author":"Sagatys","year":"2012","journal-title":"Cancer Control"},{"key":"10.1016\/j.humpath.2012.08.023_bb0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2559.2010.03698.x","article-title":"The coming of age of microRNA for B cell lymphomas","volume":"58","author":"Auer","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2012.08.023_bb0035","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MOH.0b013e3283476012","article-title":"Role of microRNAs in lymphoid biology and disease","volume":"18","author":"Fabbri","year":"2011","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.humpath.2012.08.023_bb0040","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1182\/blood-2011-07-370122","article-title":"Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis","volume":"119","author":"Iqbal","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2012.08.023_bb0045","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1053\/j.seminoncol.2011.08.006","article-title":"MicroRNAs in the pathogenesis of cancer","volume":"38","author":"Lovat","year":"2011","journal-title":"Semin Oncol"},{"key":"10.1016\/j.humpath.2012.08.023_bb0050","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2012.08.023_bb0055","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2012.08.023_bb0060","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR-15 and miR-16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2012.08.023_bb0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/cdd.2009.69","article-title":"miR-15a and miR-16-1 in cancer: discovery, function and future perspectives","volume":"17","author":"Aqeilan","year":"2010","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.humpath.2012.08.023_bb0070","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.molcel.2011.08.021","article-title":"MicroRNA destabilization enables dynamic regulation of the miR-16 family in response to cell-cycle changes","volume":"43","author":"Rissland","year":"2011","journal-title":"Mol Cell"},{"key":"10.1016\/j.humpath.2012.08.023_bb0075","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia","volume":"353","author":"Calin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2012.08.023_bb0080","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1200\/JCO.2010.29.2953","article-title":"Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study","volume":"28","author":"Schwind","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2012.08.023_bb0085","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/jcp.2008.058339","article-title":"Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR","volume":"62","author":"Siebolts","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2012.08.023_bb0090","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00277-011-1350-9","article-title":"Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma","volume":"91","author":"Fang","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.humpath.2012.08.023_bb0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood-2011-01-330704","article-title":"Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome","volume":"118","author":"Zuo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2012.08.023_bb0100","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrc883","article-title":"The Bcl2 family: regulators of the cellular life-or-death switch","volume":"2","author":"Cory","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2012.08.023_bb0105","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1182\/blood-2002-07-2009","article-title":"Cell cycle deregulation in B-cell lymphomas","volume":"101","author":"Sanchez-Beato","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2012.08.023_bb0110","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm.1880","article-title":"The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities","volume":"14","author":"Bonci","year":"2008","journal-title":"Nat Med"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817712003267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817712003267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T12:42:51Z","timestamp":1562503371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817712003267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0046817712003267"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2012.08.023","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}